Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: NWZ (11:00) - projekty uchwał: wypłata zaliczki na poczet dywidendy - 0,90 BGN (2023-10-03)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 181:Conveining Extraordinary General Meeting for 24 November 2023

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_EGM_24112023_materials.rar Conveining Extraordinary General Meeting for 24 November 2023

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 181 / 2023
Date of issue: 2023-10-03
Short name of the issuer
SOPHARMA AD
Subject
Conveining Extraordinary General Meeting for 24 November 2023
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
1. Adoption of the financial statements for the first half of 2023. Draft decision: The EGM adopts the financial statements of the Company for the first half of 2023.
2. Taking a decision under art. 30, para 5-7 of the Articles of association of the company for profit distribution and payment of an interim dividend based on the adopted 6-month financial statement. Draft decision: The EGM adopts a decision to distribute a 6-month gross dividend amounting to BGN 0.90 (90 stotinki) per share of the profit realized by the Company according to the prepared financial statements for the first half of 2023 and the remaining portion up to the full amount of the dividend exceeding the financial result for the first half of 2023 to be at the expense of the Additional Reserves of the Company in accordance with the Report on the requirements of Art. 115c of LPOS. The shareholders with dividend right are those persons entered in the registers of the Central Depository AD (CD) as at the 14th day after the day of the general meeting at which the 6-month financial statements were adopted and a decision for dividend distribution was taken. The company shall ensure the payment to the shareholders of the dividend voted at the General Meeting within 60 days of its holding. The costs for paying out the dividend are at the expense of the company. The payment of the dividend is made with the assistance of the CD. Shareholders with opened accounts with an investment intermediary (II) will receive their dividend through the respective II, and those with personal accounts in the CD will be able to receive their dividend from the branches of Eurobank Bulgaria AD (Postbank) in the country.
3. Miscellaneous.
Annexes
File Description
SFA_EGM_24112023_materials.rar
SFA_EGM_24112023_materials.rar
Conveining Extraordinary General Meeting for 24 November 2023

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-10-03 Ognian Donev Executive Director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 15.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama